 Insider Digest: What Insiders Bought on May 11, 2026 While the market speculates on where rates and the dollar are headed, major players are quietly building positions. Yesterday's insider purchases are not just numbers—they are signals. I've broken down the top 5 deals worth watching. 1. **Genedx Holdings (WGS)** — $46.8 million The largest purchase of the day by director and 10% shareholder Keith Meister. Bought at $38.84, increasing his stake by 34%. Genetic testing is a sector that will only grow. 2. **Odyssey Therapeutics (ODTX)** — $20 million Two insiders bought nearly $30 million in total. Director Li Nan and fund Sr One Capital Management. A biotech with strong insider belief in the future. 3. **Pulse Biosciences (PLSE)** — $13 million Robert Duggan (director, 10%) bought 660k shares at $19.69. A medical technology company—the insider clearly sees undervaluation. 4. **Txo Partners (TXO)** — $9.5 million Energy sector. Bob Simpson bought 750k shares at $12.61. Oil and gas are alive, and insiders know it. 5. **Mobia Medical (MOBI)** — $8 million + $2 million Two insiders bought a total of $10 million. William Harrington and Cynthia Lucchese. Medical devices—another strong signal. **Conclusion:** Biotech and healthcare are the clear focus. Three of the five largest deals are medical companies. Energy is also in play. Insiders are voting with their money against fear. Data: openinsider.com. Not investment advice.